85 related articles for article (PubMed ID: 15457162)
1. Reduction of myocardial reperfusion injury by aprotinin after regional ischemia and cardioplegic arrest.
Khan TA; Bianchi C; Voisine P; Feng J; Baker J; Hart M; Takahashi M; Stahl G; Sellke FW
J Thorac Cardiovasc Surg; 2004 Oct; 128(4):602-8. PubMed ID: 15457162
[TBL] [Abstract][Full Text] [Related]
2. Experimental study on the effects of aprotinin on myocardial ischemia and reperfusion.
Cheng G; Lan H; Sun Z; Zhang K; Du X
J Tongji Med Univ; 1997; 17(1):36-9. PubMed ID: 9639783
[TBL] [Abstract][Full Text] [Related]
3. Effects of FP15, a peroxynitrite decomposition catalyst on cardiac and pulmonary function after cardiopulmonary bypass.
Radovits T; Beller CJ; Groves JT; Merkely B; Karck M; Szabó C; Szabó G
Eur J Cardiothorac Surg; 2012 Feb; 41(2):391-6. PubMed ID: 21733708
[TBL] [Abstract][Full Text] [Related]
4. Warm ischemia provokes inflammation and regional hypercoagulability within the heart during off-pump coronary artery bypass: a possible target for serine protease inhibition.
Kon ZN; Brown EN; Grant MC; Ozeki T; Burris NS; Collins MJ; Kwon MH; Poston RS
Eur J Cardiothorac Surg; 2008 Feb; 33(2):215-21. PubMed ID: 18068996
[TBL] [Abstract][Full Text] [Related]
5. Comparison of "Huaxi-1" or "histidine-tryptophan-ketoglutarate" cardioplegia in an animal model.
Yu X; Xiong W; Zhang J; Lin J; Wang B; Huang H; Du L; Xiong J
Front Cardiovasc Med; 2024; 11():1385253. PubMed ID: 38903973
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy.
Turer AT; Hill JA
Am J Cardiol; 2010 Aug; 106(3):360-8. PubMed ID: 20643246
[TBL] [Abstract][Full Text] [Related]
7. Patients with uncontrolled hypertension subjected to cardiopulmonary bypass have altered coronary vasomotor responses to serotonin.
Harris DD; Li J; Sabe SA; Banerjee D; Pearson E; Nho JW; Ehsan A; Sodha N; Feng J; Sellke FW
Surgery; 2024 May; ():. PubMed ID: 38755032
[TBL] [Abstract][Full Text] [Related]
8. Scar Formation with Decreased Cardiac Function Following Ischemia/Reperfusion Injury in 1 Month Old Swine.
Agnew EJ; Velayutham N; Matos Ortiz G; Alfieri CM; Hortells L; Moore V; Riggs KW; Baker RS; Gibson AM; Ponny SR; Alsaied T; Zafar F; Yutzey KE
J Cardiovasc Dev Dis; 2019 Dec; 7(1):. PubMed ID: 31861331
[TBL] [Abstract][Full Text] [Related]
9. Metformin and myocardial ischemia and reperfusion injury: Moving toward "prime time" human use?
Chen Q; Lesnefsky EJ
Transl Res; 2021 Mar; 229():1-4. PubMed ID: 33148475
[No Abstract] [Full Text] [Related]
10. Ischemic Tolerance-A Way to Reduce the Extent of Ischemia-Reperfusion Damage.
Burda R; Burda J; Morochovič R
Cells; 2023 Mar; 12(6):. PubMed ID: 36980225
[TBL] [Abstract][Full Text] [Related]
11. Relevance and Recommendations for the Application of Cardioplegic Solutions in Cardiopulmonary Bypass Surgery in Pigs.
Glöckner A; Ossmann S; Ginther A; Kang J; Borger MA; Hoyer A; Dieterlen MT
Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572465
[TBL] [Abstract][Full Text] [Related]
12. The protective effects of silymarin on ischemia-reperfusion injuries: A mechanistic review.
Akbari-Kordkheyli V; Abbaszadeh-Goudarzi K; Nejati-Laskokalayeh M; Zarpou S; Khonakdar-Tarsi A
Iran J Basic Med Sci; 2019 Sep; 22(9):968-976. PubMed ID: 31807239
[TBL] [Abstract][Full Text] [Related]
13. Ischemic Preconditioning and the Role of Antifibrinolytic Drugs: Translation From Bench to Bedside.
Quinones QJ; Levy JH
Anesth Analg; 2018 Feb; 126(2):384-386. PubMed ID: 29346202
[No Abstract] [Full Text] [Related]
14. Diabetes and Cardioplegia.
Potz BA; Scrimgeour LA; Feng J; Sellke FW
J Nat Sci; 2017 Jun; 3(6):. PubMed ID: 28758150
[TBL] [Abstract][Full Text] [Related]
15. Microvascular dysfunction in patients with diabetes after cardioplegic arrest and cardiopulmonary bypass.
Feng J; Sellke F
Curr Opin Cardiol; 2016 Nov; 31(6):618-624. PubMed ID: 27652811
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppressive nano-therapeutic micelles downregulate endothelial cell inflammation and immunogenicity.
Nadig SN; Dixit SK; Levey N; Esckilsen S; Miller K; Dennis W; Atkinson C; Broome AM
RSC Adv; 2015; 5(54):43552-43562. PubMed ID: 26167278
[TBL] [Abstract][Full Text] [Related]
17. Aprotinin exerts differential and dose-dependent effects on myocardial contractility, oxidative stress, and cytokine release after ischemia-reperfusion.
McEvoy MD; Taylor AG; Zavadzkas JA; Mains IM; Ford RL; Stroud RE; Jeffords LB; Beck CU; Reeves ST; Spinale FG
Ann Thorac Surg; 2008 Aug; 86(2):568-75. PubMed ID: 18640335
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory actions of aprotinin provide dose-dependent cardioprotection from reperfusion injury.
Carter J; Buerke U; Rössner E; Russ M; Schubert S; Schmidt H; Ebelt H; Pruefer D; Schlitt A; Werdan K; Buerke M
Br J Pharmacol; 2008 Sep; 155(1):93-102. PubMed ID: 18536753
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
